You are here
Real-World Case Studies: What is Clinical Practice Telling Us? A Multidisciplinary Approach in Metastatic Castrate Resistant Prostate Cancer (X)
Sat 26 Sept / 13:00 - 14:30 / Hall A4
In the past decade, we have witnessed dramatic advances in the clinical research and management of metastatic castrate resistant prostate cancer (mCRPC) and this educational event will offer attendees an opportunity to discuss the latest strategies for optimizing mCRPC treatment. Several agents have been proven to extend overall survival and clinicians have more treatment options than ever before. Nevertheless, considerable controversy remains over how best to sequence therapies, the optimal use of imaging techniques, and the appropriate interpretation of biomarkers when evaluating treatment response. The Symposium program will use real-world clinical cases to illustrate the latest treatment approaches, providing attendees with a great opportunity to discuss challenging clinical situations directly from the practices of our panel of international experts.
M. De Santis (United Kingdom)
Maria De Santis talks about clinical trials in mCRPC and considers the results. The presentation looks at the use of biomarkers in daily practice. A panel discussion follows.
F. Sundram (United Kingdom)
Francis Sundram talks about the individualized multidisciplinary approach required to care for patients with metastatic prostate cancer, focusing on imaging.